TY  - GEN
AU  - Zhu,Rui
AU  - Zheng,Yanan
AU  - Putnam,Wendy S
AU  - Visich,Jennifer
AU  - Eisner,Mark D
AU  - Matthews,John G
AU  - Rosen,Karin E
AU  - D'Argenio,David Z
TI  - Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy
SN  - 1550-7416
PY  - 2013///1022
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Anti-Asthmatic Agents
KW  - administration & dosage
KW  - Antibodies, Anti-Idiotypic
KW  - Antibodies, Monoclonal, Humanized
KW  - Asthma
KW  - diagnosis
KW  - Biomarkers
KW  - blood
KW  - Breath Tests
KW  - Child
KW  - Computer Simulation
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Forced Expiratory Volume
KW  - Humans
KW  - Immunoglobulin E
KW  - Lung
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Models, Biological
KW  - Monte Carlo Method
KW  - Nitric Oxide
KW  - metabolism
KW  - Omalizumab
KW  - Prospective Studies
KW  - Spirometry
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1208/s12248-013-9463-9
ER  -